Recruiting at 1 site No phase Obstructive Sleep Apnea (OSA)

Clinical trial for Obstructive Sleep Apnea (OSA)

Official title Assessment of Circuit Rebreathing During CPAP Therapy

ClinicalTrials.gov ID: NCT07062770

What this study is testing

What it's testing
The study wants to learn how mask shape changes airflow and the amount of exhaled CO₂ that is breathed back during sleep.
Who it's for
Adults who have been diagnosed with obstructive sleep apnea.
What's involved
Participants will use various CPAP masks while sleeping and have their breathing and CO₂ levels measured.
Time commitment
The study lasts a few nights of sleep testing, with a short visit to set up the equipment and a brief follow‑up after the tests.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 21 to 70

You may be able to join if

  • Moderate to severe OSA (AHI\>20)
  • Self-reported CPAP users or have previously used CPAP
  • Self-reported holding pressure of maximum 13 cmH2O (if known)
  • Age: 21-70
  • BMI: 18-40 kg/m2

You likely can't join if

  • Self-reported severe mouth-breathing
  • Requirement for nocturnal supplemental oxygen or other ventilatory support
  • Severe cardiovascular or pulmonary disease
  • Any unstable or acute medical condition
  • Any additional sleep disorder, including insomnia, except for OSA.

The study team makes the final eligibility decision.

Where it is enrolling

  • Boston, Massachusetts, United States

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 21 years to 70 years. The study team makes the final eligibility decision.

Where is this trial taking place?

This study is enrolling now at Boston, Massachusetts, United States. Enter your location above to see the nearest enrolling site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.